Hedgehog信号通路在肝细胞癌发生发展中的作用及其机制
|
摘要
【研究背景】
肝细胞癌(Hepatocellular carcinoma，HCC)是我国高发的恶性肿瘤，其发病率、复发率、死亡率都有增加趋势。手术切除仍然是其最有效的治疗，但是术后由于容易复发和转移，预后仍较差，积极探讨新的治疗靶点具有重要的意义。Hedgehog(Hh)信号通路是高度保守的调控胚胎组织分化发育的通路，在脊柱动物体内，Hh蛋白与跨膜受体Ptch结合后，解除了Ptch对Smo的抑制，随后Smo从共受体上解离下来进入胞浆，将信号下传并激活锌指转录因子Gli，后者启动Ptch-1、Hip、Gli1、Wnt等目的基因的表达，进而调控细胞的增殖、分化。最近的研究发现，在前列腺癌、基底细胞癌、胰腺癌、结肠癌以及胃癌等众多恶性肿瘤中Hh信号通路异常持续激活，通过阻断该信号通路后，可以抑制肿瘤的发生和进展。但是该信号在HCC发病机制中的作用尚不清楚。
【目的】
探讨Hh信号通路在原发性肝细胞癌形成过程中的作用及其可能机制。为进一步深入了解肝细胞癌的发生、发展过程并为其诊断和治疗提供新的科学依据。
【方法】
1．构建含有肝癌组织和相应癌旁组织的组织芯片；
2．用免疫组织化学染色法检测Shh、Ihh、Ptch-1和Gli-2的表达，并对表达情况与临床病理组织学参数之间的关系进行分析；
3．采用RT-PCR方法检测Hh信号通路各分子在5株肝细胞系(L02、HepG2、Hep3B、SMMC-7721、Huh7)中的表达情况；
4．选用Hh信号活性最强的人肝癌细胞株SMMC-7721作为研究模型，使用不同浓度的Hh信号通路特异性抑制剂KAAD-cyclopamine处理细胞，采用MTT法检测细胞增殖，BrdU掺入法结合流式细胞仪检测DNA合成情况和细胞周期；
5．采用倒置显微镜观察细胞的形态学变化，AnnexinV／PI流式细胞术和TUNEL染色检测细胞凋亡率，Caspase-3活性检测试剂盒检测Caspase-3活性；
6．采用细胞划痕愈合实验、细胞体外运动和侵袭实验研究细胞粘附、运动和侵袭；
7．Westernblot检测CyclinD1、p21、caspase-3、bcl-2、E-cad等调节基因的表达。
【结果】
1．成功构建含有88个位点的组织芯片，44对肝癌和癌旁组织以一对一点阵方式排列，显微镜阅片证实取材正确，与原组织诊断吻合，结构保存良好。
2．HCC组织中Hh信号通路活性较癌旁组织显著增强。Shh、Ptch-1在HCC中的阳性表达率均高于癌旁肝组织(P＜0．05)；但二者的表达与各项临床病理指标，包括年龄、组织学分型、肿瘤大小、转移以及HBV感染之间均无明显关联(P＞0．05)。Ihh在两种组织中的表达无明显差异(P＞0．05)，其表达与各种临床病理参数无明显关联。Gli-2在HCC中的阳性表达率显著高于癌旁组织(P＜0．01)；且与组织学分型组以及肿瘤是否发上转移相关。低分化和伴有门静脉转移的病例中的表达率高于高分化组和无门静脉转移的肿瘤，差异具有统计学意义(P＜0．05)。
3．Hh信号通路在5株肝细胞系中均有不同程度表达。其中Shh、Ptch-1、Smo、Gli-2的mRNA表达水平在肝癌细胞系中明显增强，尤以SMMC-7721细胞为甚，而正常肝细胞系L02细胞中上述各分子的表达较弱。特别是Gli2在这两种细胞中的差别更为明显。Gli1在Hep3B和SMMC-7721细胞中表达水平也显著升高。而Ihh和Gli3在各种细胞系中表达均较弱。
4．应用Hh信号通路特异性抑制剂KAAD-cyclopamine处理人肝癌细胞系SMMC-7721后，细胞生长增殖能力显著减弱，而且随着KAAD-cyclopamine浓度的增加以及作用时间的延长，其抑制效果也相应提高，呈现一定的剂量和时间依赖性。BrdU掺入法结合流式细胞仪检测结果显示KAAD-cyclopamine能显著减少SMMC-7721细胞DNA合成，提高G0／G1期细胞比例并降低S期细胞比例(P＜0．05)。同时，Western blot检测结果显示p21的蛋白表达水平明显升高而CyclinD1的表达明显降低。
5．Hh信号通路阻断后，SMMC7721细胞的生存能力下降，凋亡率明显升高。干预后细胞由饱满舒展、贴壁生长状态转变为圆钝缩小、脱落悬浮状态。AnnexinV／PI检测结果显示细胞早期凋亡显著增加；TUNEL法检测发现干预组细胞凋亡明显增多，荧光显微镜下反光增强(P＜0．01)。促凋亡蛋白Caspase-3活性明显上调而抗凋亡基因bcl-2的表达下调。
6．KAAD-cyclopamine使SMMC-7721细胞的运动侵袭能力显著下降。划痕愈合试验结果显示，干预组细胞的愈合程度较对照降低了65％，细胞的运动速度明显下降(P＜0．01)。细胞体外运动能力和侵袭能力均受到明显的抑制，与对照组相分别下降了54．4±7％和48．3±11．9％(P＜0．01)。Western blot检测显示E-钙粘蛋白的表达量随着Hh信号阻断而上调。
【结论】
HCC组织中，Hh信号转导通路呈现高表达现象，并且与肝癌的分化和转移之间存在明显关联，与此一致的是，在5株肝细胞系细胞中，恶性程度较高且具有较强侵袭能力的细胞株SMMC-7721中Hh信号通路的活性最强。利用KAAD-cyclopamine特异性阻断SMMC-7721细胞中Hh通路后，可明显抑制细胞DNA合成，进而抑制肝癌细胞生长增殖能力，其机制可能与促进p21的表达，抑制CyclinD1的表达有关。阻断Hh通路后，可以降低细胞生存能力，诱导肝癌细胞凋亡，原因可能与上调了凋亡促进因子Caspase-3、下调了凋亡抑制因子bcl-2的表达有关。此外，Hh信号通路被阻断后，肝癌细胞的运动迁徙能力和侵袭力显著降低，其机制可能与促进E-钙粘蛋白的表达有关。
因此，Hh信号通路在肝细胞癌的发生发展过程中具有重要作用。参与了肝癌细胞的增殖、凋亡以及侵袭转移的多种生物学过程的调节。对Hh信号通路更加渗入、全面的探讨有助于我们进一步了解原发性肝癌的发生发展机制，为其诊断和治疗提供新的科学依据。
[Background and Objective]
Hepatocellular carcinoma(HCC)is one of the most common malignancies in ourcountry,and has the increased uptrend in incidence,recurring rate and death rate.Thehepatic resection remains the most effective treatment,but the prognosis of HCC isgenerally poor,due to the high post-operative recurrence and invasiveness of primary tumor.It is vital to explore new molecular markers for treatment strategies.Hedgehog(Hh)signaling pathway is a highly conserved system,which plays a crucial role in embryonictissue patterning,cell differentiation and proliferation.In vertebrate organisms,thesignaling pathway is initiated by the binding of ligands(Shh,Ihh,Dhh)to the membranousreceptor patched(Ptch)which in turn alleviates the suppression on smoothened(Smo),subsequently Smo triggers a series of intracellular events with resultant activation of thezinc-finger transcription effectors,glioma-associated oncogenes(Glil,Gli2,Gli3)transcription factor,which induces the expression of numerous target genes,such as Ptch-1,Hip,Gli1 and Wnt,that regulate proliferation,differentiation.Recent studies revealed thataberrantly persistent activation of Hh signaling pathway and overexpression of target geneslead to several malignant tumorigenesis,such as cancer of prostate,basal cell,pancreas,colon and stomach.However,the role of the pathway in pathogenesis of HCC is stillindistinct.
[Aim]
To investigate the effects of Hh signaling pathway on HCC and its possible mechanism,which not only furthered to detect the mechanisms of onset and developmentof HCC but provided the new scientific evidence of its molecular diagnosis and treatment.
[Methods]
1.Tissue microarray(TMA)contained HCC and corresponding tumor-adjacent livertissues were constructed.
2.The expressions of Shh,Ihh,Ptch-1 and Gli-2 in HCC tissues and correspongdingadjacent-tumor liver tissues were detected by immunohistochemistry and the correlationbetween their expressions and clinicopathologic parameter was analyzed.
3.The mRNA expressions of Hh signaling components in 5 hepatoma cell lines(L02,Hep3B,HepG2,SMMC-7721 and Huh-7)were detected by RT-PCR.
4.After treated with different concentrations of KAAD-cyclopamine,a specificinhibitor of Hh signaling pathway,Methyl thiazolyl tetrazolium(MTT)assay was used toexamine the changes in the proliferation of SMMC-7721 cells,BrdU incorporation assaywas applied to measure DNA synthesis rates and flow cytometry(FCM)was employed toanalyze the cells cycle.
5.The morphological changes of cells were observed by inverted microscope,theAnnexin V/PI and TUNEL(terminal deoxynucleotidyl transferase-mediated nick endlabeling of DNA fragmentation sites)were applied to detecte the apoptosis rate induced byKAAD-cyclopamine.The change of Caspase-3 relative activity was analyzed bycolorimetric assay.
6.Wound healing assay,Transwell assay and Modified Boyden chamber techniquewere performed to determine the cells adhesion,motility and invasiveness.
7.The expressions of the regulative genes,such as Cyclin D1,p21,Caspase-3,bcl-2,E-cadherin were detected by Western blot.
8.Statistical analysis:Date were expressed as mean±SD.Statistical correlation ofdata was cheched for significance by the ANOVA and paired Student's t test.P＜0.05 wasconsidered significant.
[Results]
1.The TMA was constructed involving 88 spots,totally 44 HCC tissues andcorresponding tumor-adjacent tissues ranked lattice one-by-one.Those spots wereconfirmed that based on correct diagnosis in line with the original organization bymicroscope,and the structure of lesions were well-preserved.
2.Hh signaling pathway activity enhanced significantly in HCC compared withcorresponding tumor-adjacent liver tissues.The expressions of Shh and Ptch-1 in HCCtissues were higher than the corresponding tumor-adjacent liver tissues(P＜0.05),but nocorrelation between expressions and clinicopathologic factors was found,including age,histological typing,tumor size,metastasize and HBV infection(P＞0.05).Neithersignificance different expression of Ihh between HCC and tumor-adjacent tissues,norrelationship between its expression and clinicopathologic factors was found.(P＞0.05).Inaddition,positive expression of Gli2 was remarkably stronger in HCC than tumor-adjacentliver tissues(P＜0.01)and overexpression of Gli2 was significantly associated with HCChistologic differentiation and portal venous invasion(P＜0.05).
3.All Hh pathway components were expressed in 5 HCC cell lines to different extent.Expression of Shh,Ptch,Smo and Gli2 mRNAs was robustly observed in hepatoma celllines,with predominance in SMMC-7721,but weaker expression in normal liver cell lines(L02)was noted,especially Gli2 was significantly over expressed in SMMC-7721 butalmost undetectable in L02.The enhanced expression of Gli1 was only observed in Hep3Band SMMC-7721.However,Ihh and Gli3 were expressed at similarly low levels in all celllines.
4.Blockade of Hh signaling pathway in SMMC-7721 cells,which pathway wassignificantly activated,by using KAAD-cyclopamine,a specific antagonist of signaling.The antagonist inhibited the cell proliferation markedly.The inhibitory effect enhancedwith increasing concentration and action time of KAAD-cyclopamine,in a dose-andtime-dependent pattern.The FCM analysis showed that KAAD-cyclopamine deduced the synthesis of DNA in SMMC-7721 cells,and induced cell cycle G1/G0 phase arrest(P＜0.05).Additionally,up-regulation of p21 and down-regulation of cyclin D1 protein expressionswere detected by Western blot.
5.Blockade of the Hh pathway reduced SMMC-7721 cells survival ability andincreased cells apoptosis.The treatment induced dramatic morphologic changes of cells,thecells transformed from a flat,elongate and adherent growth status into a rounded sharps,subsequently lost contact with neighboring cells and finally floated into medium.thetreated cells apoptosis rates increased significantly measureb by Annexin v/PI and TUNELassay(P＜0.01).Proapoptotic protein Caspase-3 expression down-regulated andanti-apoptotic gene bcl-2 expression up-regulated.
6.The motility and invasive capacity of SMMC-7721 cells were greatly suppressed byKAAD-cyclopamine.Wound assay revealed significant reductions in wound closure by＞65% for treated cells and significantly descend in mean velocities compared with controlcells(P＜0.01).Transwell Invasion assay displayed that SMMC-7721 exhibited the stronginvasive potential to penetrate the basement membrane components Matrigel,but to asignificantly lesser extent after application of KAAD-cyclopamine(P＜0.01).Accordantly,the expressions of E-cadherin was up-regulated by KAAD-cyclopamine.
[Conclusion]
Overexpression of Hh signaling pathway in HCC compared with correspondingadjacent-tumor liver tissues,and the ectopic activation of Hh pathway was associated withhistologic differentiation and portal venous invasion of HCC.All of HCC cell linesexpressed Hh pathway to different extent,with predominance in SMMC-7721,which wereregarded as poorly differentiated.Blockade Hh pathway by KAAD-cyclopaminesignificantly inhibited the DNA synthesis and resultantly inhibited proliferation inSMMC-7721 cells.Moreover,blackade Hh signaling pathway induced apoptosis of andKAAD-cyclopamine attenuated invasiveness and motility of SMMC-7721 cells remarkably.The possibely machenism are Hh signaling pathway regulate the expression of genes, including CyclinD 1,p21,Caspase3,bcl-2 and E-cadherin.
Taken together,Hh signaling pathway plays an important role in onset anddevelopment of human hepatocellular carcinama.The blockade of singaling inducedbroadly biological effects including cell growth and invasion inhibition,apoptosisenhancement in HCC.A deeper and full understanding of the function of Hh signalingpathway may provide signifieant insights into the pathogenesis,development andprognostic of hepatocellular carcinoma and a novel applicable strategy for diagnosis andtherapy.
肝细胞癌(Hepatocellular carcinoma，HCC)是我国高发的恶性肿瘤，其发病率、复发率、死亡率都有增加趋势。手术切除仍然是其最有效的治疗，但是术后由于容易复发和转移，预后仍较差，积极探讨新的治疗靶点具有重要的意义。Hedgehog(Hh)信号通路是高度保守的调控胚胎组织分化发育的通路，在脊柱动物体内，Hh蛋白与跨膜受体Ptch结合后，解除了Ptch对Smo的抑制，随后Smo从共受体上解离下来进入胞浆，将信号下传并激活锌指转录因子Gli，后者启动Ptch-1、Hip、Gli1、Wnt等目的基因的表达，进而调控细胞的增殖、分化。最近的研究发现，在前列腺癌、基底细胞癌、胰腺癌、结肠癌以及胃癌等众多恶性肿瘤中Hh信号通路异常持续激活，通过阻断该信号通路后，可以抑制肿瘤的发生和进展。但是该信号在HCC发病机制中的作用尚不清楚。
【目的】
探讨Hh信号通路在原发性肝细胞癌形成过程中的作用及其可能机制。为进一步深入了解肝细胞癌的发生、发展过程并为其诊断和治疗提供新的科学依据。
【方法】
1．构建含有肝癌组织和相应癌旁组织的组织芯片；
2．用免疫组织化学染色法检测Shh、Ihh、Ptch-1和Gli-2的表达，并对表达情况与临床病理组织学参数之间的关系进行分析；
3．采用RT-PCR方法检测Hh信号通路各分子在5株肝细胞系(L02、HepG2、Hep3B、SMMC-7721、Huh7)中的表达情况；
4．选用Hh信号活性最强的人肝癌细胞株SMMC-7721作为研究模型，使用不同浓度的Hh信号通路特异性抑制剂KAAD-cyclopamine处理细胞，采用MTT法检测细胞增殖，BrdU掺入法结合流式细胞仪检测DNA合成情况和细胞周期；
5．采用倒置显微镜观察细胞的形态学变化，AnnexinV／PI流式细胞术和TUNEL染色检测细胞凋亡率，Caspase-3活性检测试剂盒检测Caspase-3活性；
6．采用细胞划痕愈合实验、细胞体外运动和侵袭实验研究细胞粘附、运动和侵袭；
7．Westernblot检测CyclinD1、p21、caspase-3、bcl-2、E-cad等调节基因的表达。
【结果】
1．成功构建含有88个位点的组织芯片，44对肝癌和癌旁组织以一对一点阵方式排列，显微镜阅片证实取材正确，与原组织诊断吻合，结构保存良好。
2．HCC组织中Hh信号通路活性较癌旁组织显著增强。Shh、Ptch-1在HCC中的阳性表达率均高于癌旁肝组织(P＜0．05)；但二者的表达与各项临床病理指标，包括年龄、组织学分型、肿瘤大小、转移以及HBV感染之间均无明显关联(P＞0．05)。Ihh在两种组织中的表达无明显差异(P＞0．05)，其表达与各种临床病理参数无明显关联。Gli-2在HCC中的阳性表达率显著高于癌旁组织(P＜0．01)；且与组织学分型组以及肿瘤是否发上转移相关。低分化和伴有门静脉转移的病例中的表达率高于高分化组和无门静脉转移的肿瘤，差异具有统计学意义(P＜0．05)。
3．Hh信号通路在5株肝细胞系中均有不同程度表达。其中Shh、Ptch-1、Smo、Gli-2的mRNA表达水平在肝癌细胞系中明显增强，尤以SMMC-7721细胞为甚，而正常肝细胞系L02细胞中上述各分子的表达较弱。特别是Gli2在这两种细胞中的差别更为明显。Gli1在Hep3B和SMMC-7721细胞中表达水平也显著升高。而Ihh和Gli3在各种细胞系中表达均较弱。
4．应用Hh信号通路特异性抑制剂KAAD-cyclopamine处理人肝癌细胞系SMMC-7721后，细胞生长增殖能力显著减弱，而且随着KAAD-cyclopamine浓度的增加以及作用时间的延长，其抑制效果也相应提高，呈现一定的剂量和时间依赖性。BrdU掺入法结合流式细胞仪检测结果显示KAAD-cyclopamine能显著减少SMMC-7721细胞DNA合成，提高G0／G1期细胞比例并降低S期细胞比例(P＜0．05)。同时，Western blot检测结果显示p21的蛋白表达水平明显升高而CyclinD1的表达明显降低。
5．Hh信号通路阻断后，SMMC7721细胞的生存能力下降，凋亡率明显升高。干预后细胞由饱满舒展、贴壁生长状态转变为圆钝缩小、脱落悬浮状态。AnnexinV／PI检测结果显示细胞早期凋亡显著增加；TUNEL法检测发现干预组细胞凋亡明显增多，荧光显微镜下反光增强(P＜0．01)。促凋亡蛋白Caspase-3活性明显上调而抗凋亡基因bcl-2的表达下调。
6．KAAD-cyclopamine使SMMC-7721细胞的运动侵袭能力显著下降。划痕愈合试验结果显示，干预组细胞的愈合程度较对照降低了65％，细胞的运动速度明显下降(P＜0．01)。细胞体外运动能力和侵袭能力均受到明显的抑制，与对照组相分别下降了54．4±7％和48．3±11．9％(P＜0．01)。Western blot检测显示E-钙粘蛋白的表达量随着Hh信号阻断而上调。
【结论】
HCC组织中，Hh信号转导通路呈现高表达现象，并且与肝癌的分化和转移之间存在明显关联，与此一致的是，在5株肝细胞系细胞中，恶性程度较高且具有较强侵袭能力的细胞株SMMC-7721中Hh信号通路的活性最强。利用KAAD-cyclopamine特异性阻断SMMC-7721细胞中Hh通路后，可明显抑制细胞DNA合成，进而抑制肝癌细胞生长增殖能力，其机制可能与促进p21的表达，抑制CyclinD1的表达有关。阻断Hh通路后，可以降低细胞生存能力，诱导肝癌细胞凋亡，原因可能与上调了凋亡促进因子Caspase-3、下调了凋亡抑制因子bcl-2的表达有关。此外，Hh信号通路被阻断后，肝癌细胞的运动迁徙能力和侵袭力显著降低，其机制可能与促进E-钙粘蛋白的表达有关。
因此，Hh信号通路在肝细胞癌的发生发展过程中具有重要作用。参与了肝癌细胞的增殖、凋亡以及侵袭转移的多种生物学过程的调节。对Hh信号通路更加渗入、全面的探讨有助于我们进一步了解原发性肝癌的发生发展机制，为其诊断和治疗提供新的科学依据。
[Background and Objective]
Hepatocellular carcinoma(HCC)is one of the most common malignancies in ourcountry,and has the increased uptrend in incidence,recurring rate and death rate.Thehepatic resection remains the most effective treatment,but the prognosis of HCC isgenerally poor,due to the high post-operative recurrence and invasiveness of primary tumor.It is vital to explore new molecular markers for treatment strategies.Hedgehog(Hh)signaling pathway is a highly conserved system,which plays a crucial role in embryonictissue patterning,cell differentiation and proliferation.In vertebrate organisms,thesignaling pathway is initiated by the binding of ligands(Shh,Ihh,Dhh)to the membranousreceptor patched(Ptch)which in turn alleviates the suppression on smoothened(Smo),subsequently Smo triggers a series of intracellular events with resultant activation of thezinc-finger transcription effectors,glioma-associated oncogenes(Glil,Gli2,Gli3)transcription factor,which induces the expression of numerous target genes,such as Ptch-1,Hip,Gli1 and Wnt,that regulate proliferation,differentiation.Recent studies revealed thataberrantly persistent activation of Hh signaling pathway and overexpression of target geneslead to several malignant tumorigenesis,such as cancer of prostate,basal cell,pancreas,colon and stomach.However,the role of the pathway in pathogenesis of HCC is stillindistinct.
[Aim]
To investigate the effects of Hh signaling pathway on HCC and its possible mechanism,which not only furthered to detect the mechanisms of onset and developmentof HCC but provided the new scientific evidence of its molecular diagnosis and treatment.
[Methods]
1.Tissue microarray(TMA)contained HCC and corresponding tumor-adjacent livertissues were constructed.
2.The expressions of Shh,Ihh,Ptch-1 and Gli-2 in HCC tissues and correspongdingadjacent-tumor liver tissues were detected by immunohistochemistry and the correlationbetween their expressions and clinicopathologic parameter was analyzed.
3.The mRNA expressions of Hh signaling components in 5 hepatoma cell lines(L02,Hep3B,HepG2,SMMC-7721 and Huh-7)were detected by RT-PCR.
4.After treated with different concentrations of KAAD-cyclopamine,a specificinhibitor of Hh signaling pathway,Methyl thiazolyl tetrazolium(MTT)assay was used toexamine the changes in the proliferation of SMMC-7721 cells,BrdU incorporation assaywas applied to measure DNA synthesis rates and flow cytometry(FCM)was employed toanalyze the cells cycle.
5.The morphological changes of cells were observed by inverted microscope,theAnnexin V/PI and TUNEL(terminal deoxynucleotidyl transferase-mediated nick endlabeling of DNA fragmentation sites)were applied to detecte the apoptosis rate induced byKAAD-cyclopamine.The change of Caspase-3 relative activity was analyzed bycolorimetric assay.
6.Wound healing assay,Transwell assay and Modified Boyden chamber techniquewere performed to determine the cells adhesion,motility and invasiveness.
7.The expressions of the regulative genes,such as Cyclin D1,p21,Caspase-3,bcl-2,E-cadherin were detected by Western blot.
8.Statistical analysis:Date were expressed as mean±SD.Statistical correlation ofdata was cheched for significance by the ANOVA and paired Student's t test.P＜0.05 wasconsidered significant.
[Results]
1.The TMA was constructed involving 88 spots,totally 44 HCC tissues andcorresponding tumor-adjacent tissues ranked lattice one-by-one.Those spots wereconfirmed that based on correct diagnosis in line with the original organization bymicroscope,and the structure of lesions were well-preserved.
2.Hh signaling pathway activity enhanced significantly in HCC compared withcorresponding tumor-adjacent liver tissues.The expressions of Shh and Ptch-1 in HCCtissues were higher than the corresponding tumor-adjacent liver tissues(P＜0.05),but nocorrelation between expressions and clinicopathologic factors was found,including age,histological typing,tumor size,metastasize and HBV infection(P＞0.05).Neithersignificance different expression of Ihh between HCC and tumor-adjacent tissues,norrelationship between its expression and clinicopathologic factors was found.(P＞0.05).Inaddition,positive expression of Gli2 was remarkably stronger in HCC than tumor-adjacentliver tissues(P＜0.01)and overexpression of Gli2 was significantly associated with HCChistologic differentiation and portal venous invasion(P＜0.05).
3.All Hh pathway components were expressed in 5 HCC cell lines to different extent.Expression of Shh,Ptch,Smo and Gli2 mRNAs was robustly observed in hepatoma celllines,with predominance in SMMC-7721,but weaker expression in normal liver cell lines(L02)was noted,especially Gli2 was significantly over expressed in SMMC-7721 butalmost undetectable in L02.The enhanced expression of Gli1 was only observed in Hep3Band SMMC-7721.However,Ihh and Gli3 were expressed at similarly low levels in all celllines.
4.Blockade of Hh signaling pathway in SMMC-7721 cells,which pathway wassignificantly activated,by using KAAD-cyclopamine,a specific antagonist of signaling.The antagonist inhibited the cell proliferation markedly.The inhibitory effect enhancedwith increasing concentration and action time of KAAD-cyclopamine,in a dose-andtime-dependent pattern.The FCM analysis showed that KAAD-cyclopamine deduced the synthesis of DNA in SMMC-7721 cells,and induced cell cycle G1/G0 phase arrest(P＜0.05).Additionally,up-regulation of p21 and down-regulation of cyclin D1 protein expressionswere detected by Western blot.
5.Blockade of the Hh pathway reduced SMMC-7721 cells survival ability andincreased cells apoptosis.The treatment induced dramatic morphologic changes of cells,thecells transformed from a flat,elongate and adherent growth status into a rounded sharps,subsequently lost contact with neighboring cells and finally floated into medium.thetreated cells apoptosis rates increased significantly measureb by Annexin v/PI and TUNELassay(P＜0.01).Proapoptotic protein Caspase-3 expression down-regulated andanti-apoptotic gene bcl-2 expression up-regulated.
6.The motility and invasive capacity of SMMC-7721 cells were greatly suppressed byKAAD-cyclopamine.Wound assay revealed significant reductions in wound closure by＞65% for treated cells and significantly descend in mean velocities compared with controlcells(P＜0.01).Transwell Invasion assay displayed that SMMC-7721 exhibited the stronginvasive potential to penetrate the basement membrane components Matrigel,but to asignificantly lesser extent after application of KAAD-cyclopamine(P＜0.01).Accordantly,the expressions of E-cadherin was up-regulated by KAAD-cyclopamine.
[Conclusion]
Overexpression of Hh signaling pathway in HCC compared with correspondingadjacent-tumor liver tissues,and the ectopic activation of Hh pathway was associated withhistologic differentiation and portal venous invasion of HCC.All of HCC cell linesexpressed Hh pathway to different extent,with predominance in SMMC-7721,which wereregarded as poorly differentiated.Blockade Hh pathway by KAAD-cyclopaminesignificantly inhibited the DNA synthesis and resultantly inhibited proliferation inSMMC-7721 cells.Moreover,blackade Hh signaling pathway induced apoptosis of andKAAD-cyclopamine attenuated invasiveness and motility of SMMC-7721 cells remarkably.The possibely machenism are Hh signaling pathway regulate the expression of genes, including CyclinD 1,p21,Caspase3,bcl-2 and E-cadherin.
Taken together,Hh signaling pathway plays an important role in onset anddevelopment of human hepatocellular carcinama.The blockade of singaling inducedbroadly biological effects including cell growth and invasion inhibition,apoptosisenhancement in HCC.A deeper and full understanding of the function of Hh signalingpathway may provide signifieant insights into the pathogenesis,development andprognostic of hepatocellular carcinoma and a novel applicable strategy for diagnosis andtherapy.
引文
1.Ferlay J,Bray F,Pisani P,et al.Globocan 2002:Cancer Incidence,Mortality and
Prevalence Worldwide Version 2.0 Lyon:IARC Press,2004.
2．任建松，乔友林．原发性肝癌危险因素与预防研究进展[J]，中国肿瘤，2008，17：
293-296．
3. Kinzler KW, Bigner S, Bigner DD, et al. Identification of an amplified, highly expressed gene in a human glioma[J]. Science, 1987,4797(236): p. 70-73.
4. Michael CM. The hedgehog signaling network[J]. Am J Med Genet, 2003, 123A: 5-28.
5. Shachaf CM, Kopelman A, Arvanitis C, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer[J]. Nature, 2004. 431: 1112-1117.
6. Li X, Deng W, Nail CD, et al. Snail induction is an early response to Glil that determines the efficiency of epithelial transformation[J]. Oncogene, 2006, 25: 609-621.
7. Ohta M, TK, Kanai F, et al. p53-Independent negative regulation of p21/cyclin dependent kinaseinteracting protein 1 by the sonic hedgehog gliomaassociated oncogene 1 pathway in gastric carcinoma cells[J]. Cancer Res, 2005, 65: 10822-10829.
8. Lee L Rubin, Frederic J. de Sauvage. Targeting the Hedgehog pathway in cancer[J]. Drug Discovery, 2006, 5: 1026-1033.
9. van den Brink GR, Bleuming SA, Hardwick JC, et al., Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation[J]. Nature Genet, 2004, 36:277-282.
10.Dontu G,Jackson KW, McNicholas E, et al, Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells[J]. Breast Cancer Res, 2004, 6:605-615.
11.Mukherjee S, Frolova N, Sadlonova A, et al. , Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer[J].Cancer Biol Ther, 2006, 5: 674-683.
12.Berman DM, Karhadkar S, Maitra A, et al, Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours[J]. Nature, 2003, 425: 846-851.
13.Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells[J]. Cancer Res, 2007, 67: 10642-10646.
14. Velcheti V, Govinda R. Hedgehog signaling pathway and lung cancer[J]. Thorac Oncol, 2007, 2: 7-10.
15.Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer[J]. Cancer Biol Ther, 2005, 4: 1050-1054.
16.Ma X, Sheng T, Zhang Y,et al. Hedgehog signaling is activated in subsets of esophageal cancers[J]. Int J Cancer, 2006, 118:139-148.
17.Thayer SP, Magliano M, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425: 851-856.
18.Kump E, Ji J, Wernli M,H(?)usermann P, et al. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated poptosis[J]. Oncogene, 2008, 27:3856-3864.
19.Oro A E, Higgins KM, Hu Z, et al. Basal cell carcinomas in mice overexpressing sonic hedgehog[J]. Science, 1997, 276: 817-821.
20.Kayed H, Kleeff J, Keleg S, et al. Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer[J]. Int J cancer, 2004, 110: 668-676.
21.Akiyoshi T, Nakamura M, Koga K, et al. Glil down-regulated in colorectal cancers,inhibits proliferation of colon cancer cells involving Wnt signaling activation[J]. Gut, 2006,55: 991-999.
22. Matthias L, Toftg(?)rd R. Non-Canonical Activation of GLI Transcription Factors[J].Cell Cycle, 2007, 20: 2458-2462.
1．钦伦秀，孙慧川，汤钊猷．原发性肝癌研究进展[J]．中华外科杂志，2006，15：
1070-1074．
2.Rubin LL,de Sauvage FJ.Targeting the Hedgehog pathway in cancer[J].Nat Rev
Drug Discov.2006,5:1026-1033.
3.Ding Q,Motoyama J,Gasca S,et al.Diminished Sonic hedgehog signaling and lack of
floor plate differentiation in Gli2 mutant mice[J].Development,1998,125:
2533-2543.
4.Masaru K.Networking of WNT,FGF,Notch,BMP,and Hedgehog signaling pathways
during Carcinogenesis[J].Stem Cell Rev,2007,3:30-38.
5.Berman DM,Karhadkar SS,Hallahan AR,et al.Medulloblastoma growth inhibition by
hedgehog pathway blockad[J].Science,2002,297:1559-1561.
6.Berman DM,Karhadkar SS,Maitra A,et al.Widespread requirement for Hedgehog
ligand stimulation in growth of digesstive tract tumors[J].Nature,2003,425:846-851.
7.Thayer SP,Magliano MP,Heiser PW,et al.Hedgehog is an early and late mediator of
pancreatic cancer tumorigenesis[J].Nature,2003,425:851-856.
8.Oro A E,Higgins K M,Hu Z,et al.Basal cell carcinomas in mice overexpressing sonic
hedgehog[J].Science,1997,276:817-821.
9.Fendrich V,Waldmann J,Esni F,et al.Snail and Sonic Hedgehog activation in
neuroendocrine tumors of the ileum[J].Endocrine-Related Cancer,2007,14:865-874.
10.Kinzler KW,Bigner SH,Bigner DD,et al.Identification of an amplified,highly
expressed gene in a human glioma[J].Science,1987,236:70-73.
11.Regl G,Neill GW,Eichberger T,et al.Human GLI2 and GLI1 are part of a positive
feedback mechanism in Basal Cell Carcinoma[J].Oncogene,2002,21:5529-5539.
12.Lauth M,Tortgard R.Non-Canonical Activation of GLI Transcription Factors[J].Cell
Cycle,2007,6(20):2458-2463.
13.Grachtchouk M,Mo R,Yu S,et al.Basal cell carcinomas in mice overexpressing Gli2
in skin[J].Nature Genetics,2000,24(3):216-217.
14.Thiyagerajan S,Bhatia N,Rragen-Shaw S,et al.Role of GLI2 transcription factor in
growth and tumorigenicity of Prostate Cells[J].Cancer Res,2007,67(22):10642-
10646.
15．周小鸽，张劲松，张小平，等．组织芯片[J]．中华病理学杂志．2002，31：70-71．
16.Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high
throughput molecular profiling of tumor specimens[J].Nat Med,1998,4:844-847
17.Ekins R,Chu FW1 Microan'ays:their origins and applications[J].Trends Biotechnol,
1999,17:217-218.
18.Kayed H,Kleeff J,Keleg S,et al.Indian hedgehog signaling pathway:expression and
regulation in pancreatic cancer[J].Int J Cancer,2004,110:668-676.
19.Ikram MS,Neill GW,Regl G,et al.GLI2 is expressed in normal human epidermis and
BCC and induces GLI1 expression by binding to its promoter.J Invest Dermatol,2004,
122:1503-1509.
20.Karhadkar SS,Bova GS,Abdallah N,et al.Hedgehog signaling in prostate
regeneration,neoplasia and metastasis[J].Nature,2004,431:707-712.
21.Pola R,Ling LE,Aprahamian TR,et al.Postnatal recapitulation of embryonic
hedgehog pathway in response to skeletal muscle ischemia[J].Circulation,2003,
108:479-485.
22.Sicklick JK,Li YX,Jayaraman A,et al.Dysregulation of the Hedgehog pathway in
human hepatocarcinogenesis[J].Carcinogenesis,2006,27:748 - 757.
1.Porter JA,Young KE,Beachy PA.Cholesterol modification of hedgehog signaling
proteins in animal development[J].Science,1996,274:255-259.
2.Cooper MK,Porter JA,Young KE,et al.Teratogen mediated inhibition of target tissue
response to Shh signaling[J].Science,1998,280:1603-1607.
3.Taipale J,Chen JK,Cooper MK,et al.Effects of oncogenic mutations in Smoothened
and Patched can be reversed by cyclopamine[J].Nature,2000,406:1005-1009.
4.Berman DM,Karhadkar SS,Hallahan AR,et al.Medullo blastoma growth inhibition
by hedgehog pat hway blockade[J].Science,2002,297:1559-1561.
5.Karhadkar S S,Bova G S,Abdallah N,et al.Hedgehog signaling in prostate
regeneration,neoplasia and metastasis[J].Nature,2004,431:707-712.
6.Kiselyov AS.Targeting the Hedgehog signaling pathway with small molecules[J].
Anticancer Agents Med Chem,2006,6:445-449.
7.Lauth M,Bergstrem A,Shimokawa T,et al.Inhibition of GLI2 mediated transcription
and tumor cell growth by small-molecule antagonists[J].Proc Natl Acad Sci USA,
2007,104:8455-8460.
8.Watkins DN,Bennan DM,Burkholder SG,et al.Hedgehog signalling within airway
epithelial progenitors and insmall-cell lung cancer[J].Nature,2003,422:313-317.
9.Thayer,SP,di Magliano MP,et al.Hedgehog is an early and late mediator of
pancreatic cancer tumorigenesis[J].Nature,2003,425:851-856.
10.Vogt A,Chuang PT,et al.Immunoprevention of basal cell carcinomas with
recombinant hedgehog-interacting protein[J].Science,2004,199:753-761.
11.Curis Inc:Curis receives approval to start phase I clinical trial of CUR-61414 for
treatment of sporadic basal cell carcinoma - new therapeutic approach offers patients
an alternative to surgery.Press Release,2001:5.
12.van den Heuvel M,Ingham PW.Smoothened encodes a receptor-like serpentine
protein required for hedgehog signaling[J].Nature,1996,382:547-551.
13.Hunter T,Pines J.Cyclins and cancer II:cyclin D and CDK inhibitors come of age[J].
Cell,1994,79:573-582.
14.Jensen PO,Larsen JK,Christensen JJ,et al.Discrimination of bromodeoxyuridine
isbdlled and unlabelled mitotic cells in flow cytometric bromodeoxyuriding/LNA
analysis[J].Cytometry,1994,15:154-156.
15.DolbeareF.Bromodeoxyuridine a diagnostic tool in bililigy and medicine,Part 1
Historocal perspectives histochemical methods and cell kinetics.Histochem[J].1995;
27:339-341.
16.Zwijsen RM,Wientjens E,Klompmaker R,et al.CDK-independent activation of
estrogen receptor by cyclin D1[J].Cell,1997,88:405-415.
17．胥健敏，文剑明，张萌，等．肝细胞癌细胞周期蛋白D1基因的扩增和表达[J]．中
华病理学杂志．2004；33：26-30．
18.Joo M,Kang YK,Kim MR,et al.Cyclin D1 overexpression in hepatocellular
carcinoma[J].Liver.2001;21:89-95.
19.Simile MM,De Miglio MR,Muroni MR,et al.Down-regulation of c-myc and Cyclin
D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in
vitro growth of HepG2 and Morris 5123 liver cancer cells[J].Carcinogenesis.2004;25:
333-341.
20.Hobeika AC,Etienne W,Torres BA,et al.IFN-gamma induction of p21 is required
for cell cycle inhibition and suppression of apoptosis[J].J Interferon Cytokine Res,
1999,19:1351-1361.
21. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression mechanisms and consequences[J]. Cancer Res, 2005, 65: 3980-3985.
22. Duman-Scheel M, Weng L, Xin S, et al. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E[J]. Nature, 2002,417:299-303
23. Regl G, Kasper M, Schnidar H ,et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal t ransduction is predominantly mediated by GLI2[J] . Cancer Res, 2004,64:7724-7731.
24. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis[J]. Proc Natl Acad Sci USA. 2007,104:5103-5108.
1.Vermes I,Haanen C,Steffens-Nakken H,et al.A novel assay for apoptosis:flow
cytometric detcetion of phosphatidylserine expression onearly apoptotic cells using
fluorescein labeled AnnexinV[J].J Immunol Methods,1995,184:39-51
2.Hugo van Genderen,Heidi Kenis,Petra Lux,et al.In vitro measurement of cell death
with the annexin A5 affinity assay[J].Nature protocol,2006,1:363-367.
3.Huang Z.The chemical biology of apoptosis.Exploring protein-protein interactions
and the life and death of cells with small molceules[J].Chem Biol.2002,9:1059-1072.
4.Jean-Baptiste Charrier,Frangoise Lapointe,Nicole M.Anti-apoptotic role of Sonic
hedgehog protein at the early stages of nervous system organogenesi[J].Development, 2001,128:4011-4020.
5.Varas A, Hernandez-Lopez C, Valencia J, et al. Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling[J]. J Leukoc Biol, 2008;83:1476-1483.
6.Venters SJ and Ordahl CP. Persistent myogenic capacity of the dermomyotome dorsomedial lip and restriction of myogenic competence[J]. Development, 2003;129:3873-3885.
7.Coffman CR, Strohm RC, Oakley FD, et al. Identification of X-linked genes required for migration and programmed Cell death of drosophila melanogaster germ Cells[J].Genetics, 2002; 162:273-284.
8.McCarthy RA, Barth JL, Chintalapudi MR, et al. Megalin functions as an endocytic sonic hedgehog receptor[J]. J Biol Chem, 2002; 277:25660-25667.
9.Yuzhu T, Elzbieta A. Swietlicki, et al. Increased apoptosis and accelerated epithelial migration following inhibition of hedgehog signaling in adaptive small bowel post-resection[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290:1280-1288.
10.Thayer SS,di Magliano MP, Patrick W Heiser, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425: 851-856.
11.Sheng G,Guo J, and Warner BW. Epidermal growth factor receptor signaling modulates apoptosis via p38α MAPK-dependent activation of Bax in intestinal epithelial cells[J]. Am J Physiol Gastrointest Liver Physiol, 2007; 293:599-606.
12.Narita S, So A, Ettinger S, et al. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer[J]. Clin Cancer Res. 2008 14:5769-5777.
13.Liao X, Siu MK, Au CW, et al. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis.2009,30:131-40.
14.Tanori M, Mancuso M, Pasquali E, et al. PARP-1 cooperates with Ptcl to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis. 2008 29:1911-1919.
15.Warzecha J, Bonke L, Koehl U, et al. The hedgehog inhibitor cyclopamine induces apoptosis in leukemic cells in vitro[J]. Leuk Lymphoma. 2008; 49:2383-2386.
16.Lindemann RK. Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res. 2008; 68:961-964.
17.Qualtrough D, Buda A, Gaffield W, et al. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment[J]. Int J Cancer, 2004; 110:831-837.
18.Li P, Nijhawan D, Budihardjo I, et al. Cytochrome C and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade[J]. Cell, 1997, 91:479-489.
19.Yang J , Liu X , Bhalla K, et al. Prevention of apoptosis by Bc1-2: release of cytochrome c from mitochondria blocked[J]. Science, 1997 ,275 :1129-1132.
20.Kato J, Kuwabara Y, Mitana M , et al.Expression of survivin in esophageal cancer:correlation with the prognosis and response to chemotherapy[J].Int J Cancer , 2001,95:92-95.
21.Manion MK and Hoekenbery DM. Targeting Bcl-2 related proteins in cancer therapy[J].Cancer Biol Ther, 2003, 2: 5105-5114.
22.Regl G,Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004;64:7724-7731.
23.Krajewska M, Wang HG,Krajewski S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease[J]. Cancer Res,1997, 57: 1605-1613.
24.Fujikawa K, Shiraki K, Sugimoto K, et al . Reduced expression of ICE/Caspase 1 and CPP32/ Caspase 3 in human hepatocellular carcinoma [J] Anticancer Res , 2000, 20:1927-1932.
25.Abe Y,Oda-Sato E,Tobiume K,et al.Hedgehog signaling overrides p53-mediated
tumor suppression by activating Mdm2[J].Proc Natl Acad Sci U S A.2008,
105:4838-4843.
26.Sabbatini P,Han J,Chiou SK,et al.Interleukin 1 beta converting enzyme-like
proteases are essential for p53-mediated transcriptionally dependent apoptosis[J].Cell
Growth Differ,1997,8:643-653.
27.Jin YH,Yoo KJ,Lee YH,et al.Caspase 3-mediated cleavage of p21 associated with
the cyclin A-cyclin-dependent kinase 2 comoplex is a prerequisite for apoptosis in
SK-HEP-1 cell[J].J Biol Chem,2000,275:30256-30263.
1． 陈孝平，裘法祖，吴在德．原发性肝癌要按个体化采用以手术为主的综合治疗[J]．中华外科杂志，2003，41：161-162．
2．晋云，董家鸿．肝癌转移机制研究进展[J]．西南国防医药，2008，18：134-137．
3.Tang ZY,Ye SL,Liu YK,et al.A decade's studies on metastasis of hepatocellular carcinoma.J Cancer Res Clin Oncol,2004,130:187
4.Changqing Yang,Michael Zeisberg,Julie C,et al.Integrin α1β1 and α2β1 are the key regulators of hepatocarcinoma cell Invasion across the fibrotic matrix microenvironment[J].Cancer Res,2003,63:8312-8317.
5.Takeichi M.Cadherin cell adhesion receptors as a morphogenetic regulator.Science.1991,251:1451-1455.
6.Becker KF,Kremmer E,Eulitz M,et al.Analysis of E-cadherin in diffuse-type gastric cancer using a mutation specific monoclonal antibody[J].Am J Pathol,1999,155:1803-1809.
7.Vogt A,PT Chuang,et al.Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein[J].Science,2004,199:753-761.
8.Yang Y,Rao R,Shen J,et al.Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion[J].Cancer Res,2008,68:4833-4842
9.Perl AK,Wligenbus P,Dahl U,et al.Expressionof p-cadherin identifies prostate specific-antigen-negative cells inepithelial tissues of male sexual accessory organs and in prostatic carcinomas[J].Nature,1998,392:1901-1903.
10.Osada T,SakamotoM,Ino Y,et al.E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma[J].Hepatology,1996,24:1460-1467.
11.Stambolic V,Mak TW,Woodgett JR.Modulation of cellular apoptotic potential:contributions to oncogenesis[J].Oncogene,1999;18:6094-6103.
12.Thiery JP.Epithelial-mesenchymal transitions in tumour progression[J].Nat Rev Cancer 2002;2:442-454
13.Mayer B,Johnson JP,Leitl F,et al.E-cadherin expression in primary and metastatic gastric cancer:Down-regulation correlates with cellular dedifferentiation and glandular disintegration[J].Cancer Res,1993,53:1690-1695.
14.Moll R,MitzeM,Frixen UH,et al.Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas[J].Am J Pathol,1993,143:1731-1742.
15.Krishnadath KK,Tilanus HW,van Blankenstein M,et al.Reduced expression of the eadherin-catenin comp lex in oesophageal adenocarcinoma correlates with poor p rognosis[J].J Pathol,1997,182:331-338
16．姚昱，周信达，刘银坤，等．上皮型钙粘蛋白(E-cad)在高侵袭性肝细胞癌中的表达[J]．中华消化杂志，1998，18：33-35．
17．成峰，王学浩，钱建民，等．E-钙粘蛋白、syndecan-1蛋白在HCC中的表达与肝癌侵袭的关系[J]．中华普通外科杂志，2003，3：141-142．
18.Wei Y,Van Nhieu JT,Prigent S,et al.Altered expression of E-cadherin in hepatocellular carcinoma:correlations with genetic alteratin,beta-catenin expression,and clinical feature[J].Hepatology,2002,36:692-701.
1.Nusslein-Vblhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287: 795-801.
2.Bertrand N and Dahmane N. Sonic hedgehog signaling inforebrain development and its interactions with pathways that modity its effeets[J]. Trends Cell Biol, 2006,116:597-605.
3.di Marcotullio L, Ferretti E, Greco A, et al. Multiple ubiquitin-dependent processing pathways regulate hedgehog/gli signaling: implications for cell development and tumorigenesis[J]. Cell Cycle, 2007, 6:390-393.
4.Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol, 2005,6: 306-317
5.Elia D, Madhala D, Ardon E, et al. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways[J]. Biochim Biophys Acta 1773: 1438-1446,2007.
6.Palma V, Lim DA, Dahmane N, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain[J]. Development, 2005, 132: 335-344.
7.Beachy PA, Karhadkar SS, Berman DM: Tissue repair and stem cell renewal in carcinogenesis[J]. Nature, 2004, 432:324-331.
8.Pathi S. Comparative biological responses to human Sonic, Indian and Desert hedgehog[J]. Mech Dev, 2001, 106:107-117.
9.Ruiz I Altaba A, Palma V, Dahmane N. Gli and hedgehog in cancer: tumor, embryos and stem cells[J]. Nat Rev Cancer, 2002, 2:361-372.
10.McMahon AP, Ingham PW, Tabin CJ. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol, 2003, 53:1-114.
11.Kayed H, Kleeff J, Keleg S, et al. Distribution of Indian hedgehog and its receptors patched and smoothened in human chronic pancreatitis[J]. J Endocrinol, 2003,178:467-478.
12.Carpenter D, Stone DM, Brush J, et al. Characterization of two patched receptors for the vertebrate hedgehog protein family[J]. Proc Natl Acad Sci USA, 1998, 95:13630-13634.
13.Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles[J]. Genes Dev, 2001,15:3059-3087.
14.Hooper JE. Smoothened translates Hedgehog levels into distinct responses[J].Development, 2003,130:3951-3963.
15.Chen Y, Struhl G. Dual roles for patched in sequestering and transducing Hedgehog[J].Cell, 1996, 87:553-563.
16.Ruiz I Altaba A. Gli protein and hedgehog signaling in development and cancer[J].Trends Genet, 1999,15:481-425.
17.Kalderon D. Hedgehog signaling: Costa1-2 bridges the transduction gap[J]. Curr Biol,2004,14:64-69.
18.Jiang J, Srtuhl G. Regulation of the Hedgehog and Wingless signaling pathway by the F-box/WD40-repeat protein Slinmb[J]. Nature, 1998, 391:493-496.
19.Kinzler KW, Bingner SH, Bigner DD, et al. Identification of an amplified, highly expressed gene in a human glioma [J]. Science, 1987,236:70-73.
20.Ruiz i Altaba A, Nguyen V, Palma V, et al. The emergent design of the neural tube:prepattern, SHH morphogen and GLI code[J]. Curr Opin Genet Dev, 2003, 13:513-521.
21.Ruiz I Altaba A. Catehing a Gli-mpse of Hedgehog[J]. 1997,190:193-196.
22.Nataka K, Nagai T, Aruga J, et al. Xenopus Zic family and its role in neural and neural crest development[J]. Mech Dev, 1998, 75:43-51.
23. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma[J]. Nat Genet, 2003, 31:306-310.
24. Mullor JL, Sanchez P, Altaba AR. Pathways and consequences: Hedgehog signaling in human disease[J]. Trends Cell Biol, 2002,12:562-569.
25. Chuang PT, McMahon AP. Vertebrate Hedgehog signaling modulated by induction of a Hedgehog-binding protein[J]. Nature, 1999,397:617-621.
26. Keeler, RF, Binns, W. Chemical compounds of Veratrum californicum related to congenital ovine cyclopian malformations. Extraction of active material. Proc.Soc.Exp. Biol. Med. 1964, 116,123-127.
27. Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine[J]. Nature, 2000,406: 1005-1009.
28. Chen JK, Taipale J, Cooper MK, et al. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened[J]. Genes & Develop. 2002,16, 2743-2748.
29. Chen JK, Taipale J, Young KE, et al. Small molecule modulation of Smoothened activity[J]. Proc Natl Acad Sci USA, 2002, 99: 14071-14076.
30. Yang TY, Chen SC, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus and induces an angioproliferative disease resembling Kaposi's sarcoma[J]. J Exp Med, 2000, 191:445-454.
31. Williams JA, Guieherit MO, et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell careinoma-like lesions[J]. Proc Natl Acad Sci USA, 2003, 100:4616-4621.
32. Curis Inc: Curis receives approval to start phase I clinical trial of CUR-61414 for treatment of sporadic basal cell carcinoma-new therapeutic approach offers patients an alternative to surgery. Press Release, 2001:5.
33. Curis Inc: Genentech and Curis halt development of topical Hedgehog antagonist for skin cancer. Press Release (2006):July 12.
34. Kinzler KW, Bingner SH, Bingner DD, et al. Identification of an amplified, highly expressed gene in a human glioma [J]. Science, 1987, 236:70-73.
35. Zurawel RH, Allen C, Wechaler-Reya, et al. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice[J]. Genes Chromosomes Cancer, 2000, 28: 77-81.
36. Smyth I, Narang MA, Evans T, et al. Isolation and characerization of human patched2(PTCH2), a putative tumor suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome lp32[J]. Hum Mol Genet, 1999, 8:291-297.
37. Reifenberger J, Wolter M, Weber RG, et al. Missense mutation in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroeetodermal tumors of the central nervous system[J]. Cancer Res, 1998,58:1798-1803.
38. Xie J, Murone M, Luoh SM, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma[J]. Nature, 1998,391:90-92.
39. Hahn H, Wicking C, Zaphiropoulos PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 1996, 85:841-851
40. Hahn H, Christiansen J, Wicking C,et al. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities[J]. J Biol Chem. 1996; 271:12125-12128.
41. Dahmane N , Sanchez P , Gitton Y, et al. The Sonic Hedgehog-Gli pat hway regulates dorsal brain growt h and tumorigenesis[J]. Dev, 2001,128:5201-5212.
42. Berman DM , Karhadkar SS , Hallahan AR , et al. Medulloblastoma growth inhibition by hedgehog pat hway blockade[J]. Science, 2002, 297:1559-1561.
43. Lee Y, Kawagoe R , Sasai K, et al . Loss of suppressor of fused function promotes tumorigenesis[J]. Oncogene,2007,26: 6442-6447.
44. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Human Mol.Genet. 2001,10:757-762
45. Dahmane N, Lee J, Robins P, et al. Activation of the transcription factor Glil and the Sonic hedgehog signalling pathway in skin tumours[J]. Nature, 1997, 389: 876-881.
46. Booth DR. The hedgehog signalling pathway and its role in basal cell carcinoma. Cancer Metastasis Rev, 1999,18: 261- 284.
47.Nilsson M, Unden AB, Krause D, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci U S A , 2000, 97:3438- 3843.
48.Vogt A, Chuang PT, et al. Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein[J]. J Exp Med, 2004,199:753-761.
49.Thayer S P, Di Magliano M P, Heiser P W,et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003,425: 851-856.
50.Berman DM, Karhadkar SS, Maitra A, et al. Wide spread requirement for Hedgehog ligand stimulation in growth of digestive tract tumour[J]. Nature, 2003,425:846-851
51.Georg F, Nils H, Surajit D, et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer[J]. Gut. 2008, 57:1420-1430.
52.Hu WG, Liu T, Xiong JX, Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells[J]. Acta Pharmacol Sin, 2007,28: 1224-1230.
53.Vanchieri C.Scientists hopeful as they uncover molecular clues to prostate cancer[J].JNCI,2005, 97:168-170.
54.Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 2004, 431:707-712.
55.Sanchez P, Hernandez AM, Stecca B, et al.Inhibition of prostate cancer proliferation by interference with sonic hedgehog-glil signaling. Proc Natl Acad Sci, 2004, 101:12561-12565
56.Saravanan T, Neehar B, Shannon RS, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells[J]. Cancer Res, 2007, 67: 10642-10646
57.Fan L, Pepicelli CV, Dibble CC, et al. Hedgehog signaling promotes prostate xenograft tumor growth[J]. Endocrinology, 2004, 145: 3961-3970.
58. Sanchez P, Hernandez AM, Stecca B, et al. Inhibition of p rostate cancer p roliferation by interference with Sonic hedgehog-Gli-lsignaling[J]. Proc Natl Acad Sci USA, 2004,101: 12561-12566.
59. Michael T Lewis.Hedgehog signaling in mouse mammary gland development and neoplasia[J].J Mammay Gland Biol Neopl, 2001,6(l):53-66.
60. Xie J, Johnson RL, Zhang X, et al. Mutations of PATCHED gene in several types of sporadic extracutaneous tumor[J]. Cancer Res, 1997, 57:2369-2372.
61. Kubo M, Nakamura M, Tasaki A et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer[J]. Cancer Res, 2004, 64: 6071-6074.
62. Sterling JA, Oyajobi BO, Grubbs B, et al. The Hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells[J]. Cancer Res 2006; 66: 7548-7554.
63. Monzo M, Relano E, Gutirrez J, et al. Sonic hedgehog(Shh) mutations in resected non-small cell lung cancer (NSCLC). Lung Cancer, 2000,29: 187-188.
64. Watkins DN , Berman DM, Baylin SB. Hedgehog signaling: progenitor phenotype in small2cell lung cancer[J]. Cell Cycle, 2003,2:196-198.
65. Mori Y, Okumura T, Tsunoda S, et al. Gli-1 Expression Is Associated with Lymph Node Metastasis and Tumor Progression in Esophageal Squamous Cell Carcinoma[J].Oncology, 2006, 70: 378-389.
66. Ma X, Chen K, Huang S, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas[J]. Carcinogenesis, 2005, 26: 1698-1705.
67. Olsen CL, Hsu PP, Glienke J, et al. Hedgehog-interacting protein is highly expressed in endothelial cells, but down-regulated during angiogenesis and in several human tumors[J]. BMC Cancer, 2004, 4: 43.
68. Volker F, Waldmann J, Farzad E, et al. Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum[J]. Endocrine Related Cancer, 2007,14: 865-874.
Prevalence Worldwide Version 2.0 Lyon:IARC Press,2004.
2．任建松，乔友林．原发性肝癌危险因素与预防研究进展[J]，中国肿瘤，2008，17：
293-296．
3. Kinzler KW, Bigner S, Bigner DD, et al. Identification of an amplified, highly expressed gene in a human glioma[J]. Science, 1987,4797(236): p. 70-73.
4. Michael CM. The hedgehog signaling network[J]. Am J Med Genet, 2003, 123A: 5-28.
5. Shachaf CM, Kopelman A, Arvanitis C, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer[J]. Nature, 2004. 431: 1112-1117.
6. Li X, Deng W, Nail CD, et al. Snail induction is an early response to Glil that determines the efficiency of epithelial transformation[J]. Oncogene, 2006, 25: 609-621.
7. Ohta M, TK, Kanai F, et al. p53-Independent negative regulation of p21/cyclin dependent kinaseinteracting protein 1 by the sonic hedgehog gliomaassociated oncogene 1 pathway in gastric carcinoma cells[J]. Cancer Res, 2005, 65: 10822-10829.
8. Lee L Rubin, Frederic J. de Sauvage. Targeting the Hedgehog pathway in cancer[J]. Drug Discovery, 2006, 5: 1026-1033.
9. van den Brink GR, Bleuming SA, Hardwick JC, et al., Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation[J]. Nature Genet, 2004, 36:277-282.
10.Dontu G,Jackson KW, McNicholas E, et al, Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells[J]. Breast Cancer Res, 2004, 6:605-615.
11.Mukherjee S, Frolova N, Sadlonova A, et al. , Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer[J].Cancer Biol Ther, 2006, 5: 674-683.
12.Berman DM, Karhadkar S, Maitra A, et al, Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours[J]. Nature, 2003, 425: 846-851.
13.Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells[J]. Cancer Res, 2007, 67: 10642-10646.
14. Velcheti V, Govinda R. Hedgehog signaling pathway and lung cancer[J]. Thorac Oncol, 2007, 2: 7-10.
15.Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer[J]. Cancer Biol Ther, 2005, 4: 1050-1054.
16.Ma X, Sheng T, Zhang Y,et al. Hedgehog signaling is activated in subsets of esophageal cancers[J]. Int J Cancer, 2006, 118:139-148.
17.Thayer SP, Magliano M, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425: 851-856.
18.Kump E, Ji J, Wernli M,H(?)usermann P, et al. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated poptosis[J]. Oncogene, 2008, 27:3856-3864.
19.Oro A E, Higgins KM, Hu Z, et al. Basal cell carcinomas in mice overexpressing sonic hedgehog[J]. Science, 1997, 276: 817-821.
20.Kayed H, Kleeff J, Keleg S, et al. Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer[J]. Int J cancer, 2004, 110: 668-676.
21.Akiyoshi T, Nakamura M, Koga K, et al. Glil down-regulated in colorectal cancers,inhibits proliferation of colon cancer cells involving Wnt signaling activation[J]. Gut, 2006,55: 991-999.
22. Matthias L, Toftg(?)rd R. Non-Canonical Activation of GLI Transcription Factors[J].Cell Cycle, 2007, 20: 2458-2462.
1．钦伦秀，孙慧川，汤钊猷．原发性肝癌研究进展[J]．中华外科杂志，2006，15：
1070-1074．
2.Rubin LL,de Sauvage FJ.Targeting the Hedgehog pathway in cancer[J].Nat Rev
Drug Discov.2006,5:1026-1033.
3.Ding Q,Motoyama J,Gasca S,et al.Diminished Sonic hedgehog signaling and lack of
floor plate differentiation in Gli2 mutant mice[J].Development,1998,125:
2533-2543.
4.Masaru K.Networking of WNT,FGF,Notch,BMP,and Hedgehog signaling pathways
during Carcinogenesis[J].Stem Cell Rev,2007,3:30-38.
5.Berman DM,Karhadkar SS,Hallahan AR,et al.Medulloblastoma growth inhibition by
hedgehog pathway blockad[J].Science,2002,297:1559-1561.
6.Berman DM,Karhadkar SS,Maitra A,et al.Widespread requirement for Hedgehog
ligand stimulation in growth of digesstive tract tumors[J].Nature,2003,425:846-851.
7.Thayer SP,Magliano MP,Heiser PW,et al.Hedgehog is an early and late mediator of
pancreatic cancer tumorigenesis[J].Nature,2003,425:851-856.
8.Oro A E,Higgins K M,Hu Z,et al.Basal cell carcinomas in mice overexpressing sonic
hedgehog[J].Science,1997,276:817-821.
9.Fendrich V,Waldmann J,Esni F,et al.Snail and Sonic Hedgehog activation in
neuroendocrine tumors of the ileum[J].Endocrine-Related Cancer,2007,14:865-874.
10.Kinzler KW,Bigner SH,Bigner DD,et al.Identification of an amplified,highly
expressed gene in a human glioma[J].Science,1987,236:70-73.
11.Regl G,Neill GW,Eichberger T,et al.Human GLI2 and GLI1 are part of a positive
feedback mechanism in Basal Cell Carcinoma[J].Oncogene,2002,21:5529-5539.
12.Lauth M,Tortgard R.Non-Canonical Activation of GLI Transcription Factors[J].Cell
Cycle,2007,6(20):2458-2463.
13.Grachtchouk M,Mo R,Yu S,et al.Basal cell carcinomas in mice overexpressing Gli2
in skin[J].Nature Genetics,2000,24(3):216-217.
14.Thiyagerajan S,Bhatia N,Rragen-Shaw S,et al.Role of GLI2 transcription factor in
growth and tumorigenicity of Prostate Cells[J].Cancer Res,2007,67(22):10642-
10646.
15．周小鸽，张劲松，张小平，等．组织芯片[J]．中华病理学杂志．2002，31：70-71．
16.Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high
throughput molecular profiling of tumor specimens[J].Nat Med,1998,4:844-847
17.Ekins R,Chu FW1 Microan'ays:their origins and applications[J].Trends Biotechnol,
1999,17:217-218.
18.Kayed H,Kleeff J,Keleg S,et al.Indian hedgehog signaling pathway:expression and
regulation in pancreatic cancer[J].Int J Cancer,2004,110:668-676.
19.Ikram MS,Neill GW,Regl G,et al.GLI2 is expressed in normal human epidermis and
BCC and induces GLI1 expression by binding to its promoter.J Invest Dermatol,2004,
122:1503-1509.
20.Karhadkar SS,Bova GS,Abdallah N,et al.Hedgehog signaling in prostate
regeneration,neoplasia and metastasis[J].Nature,2004,431:707-712.
21.Pola R,Ling LE,Aprahamian TR,et al.Postnatal recapitulation of embryonic
hedgehog pathway in response to skeletal muscle ischemia[J].Circulation,2003,
108:479-485.
22.Sicklick JK,Li YX,Jayaraman A,et al.Dysregulation of the Hedgehog pathway in
human hepatocarcinogenesis[J].Carcinogenesis,2006,27:748 - 757.
1.Porter JA,Young KE,Beachy PA.Cholesterol modification of hedgehog signaling
proteins in animal development[J].Science,1996,274:255-259.
2.Cooper MK,Porter JA,Young KE,et al.Teratogen mediated inhibition of target tissue
response to Shh signaling[J].Science,1998,280:1603-1607.
3.Taipale J,Chen JK,Cooper MK,et al.Effects of oncogenic mutations in Smoothened
and Patched can be reversed by cyclopamine[J].Nature,2000,406:1005-1009.
4.Berman DM,Karhadkar SS,Hallahan AR,et al.Medullo blastoma growth inhibition
by hedgehog pat hway blockade[J].Science,2002,297:1559-1561.
5.Karhadkar S S,Bova G S,Abdallah N,et al.Hedgehog signaling in prostate
regeneration,neoplasia and metastasis[J].Nature,2004,431:707-712.
6.Kiselyov AS.Targeting the Hedgehog signaling pathway with small molecules[J].
Anticancer Agents Med Chem,2006,6:445-449.
7.Lauth M,Bergstrem A,Shimokawa T,et al.Inhibition of GLI2 mediated transcription
and tumor cell growth by small-molecule antagonists[J].Proc Natl Acad Sci USA,
2007,104:8455-8460.
8.Watkins DN,Bennan DM,Burkholder SG,et al.Hedgehog signalling within airway
epithelial progenitors and insmall-cell lung cancer[J].Nature,2003,422:313-317.
9.Thayer,SP,di Magliano MP,et al.Hedgehog is an early and late mediator of
pancreatic cancer tumorigenesis[J].Nature,2003,425:851-856.
10.Vogt A,Chuang PT,et al.Immunoprevention of basal cell carcinomas with
recombinant hedgehog-interacting protein[J].Science,2004,199:753-761.
11.Curis Inc:Curis receives approval to start phase I clinical trial of CUR-61414 for
treatment of sporadic basal cell carcinoma - new therapeutic approach offers patients
an alternative to surgery.Press Release,2001:5.
12.van den Heuvel M,Ingham PW.Smoothened encodes a receptor-like serpentine
protein required for hedgehog signaling[J].Nature,1996,382:547-551.
13.Hunter T,Pines J.Cyclins and cancer II:cyclin D and CDK inhibitors come of age[J].
Cell,1994,79:573-582.
14.Jensen PO,Larsen JK,Christensen JJ,et al.Discrimination of bromodeoxyuridine
isbdlled and unlabelled mitotic cells in flow cytometric bromodeoxyuriding/LNA
analysis[J].Cytometry,1994,15:154-156.
15.DolbeareF.Bromodeoxyuridine a diagnostic tool in bililigy and medicine,Part 1
Historocal perspectives histochemical methods and cell kinetics.Histochem[J].1995;
27:339-341.
16.Zwijsen RM,Wientjens E,Klompmaker R,et al.CDK-independent activation of
estrogen receptor by cyclin D1[J].Cell,1997,88:405-415.
17．胥健敏，文剑明，张萌，等．肝细胞癌细胞周期蛋白D1基因的扩增和表达[J]．中
华病理学杂志．2004；33：26-30．
18.Joo M,Kang YK,Kim MR,et al.Cyclin D1 overexpression in hepatocellular
carcinoma[J].Liver.2001;21:89-95.
19.Simile MM,De Miglio MR,Muroni MR,et al.Down-regulation of c-myc and Cyclin
D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in
vitro growth of HepG2 and Morris 5123 liver cancer cells[J].Carcinogenesis.2004;25:
333-341.
20.Hobeika AC,Etienne W,Torres BA,et al.IFN-gamma induction of p21 is required
for cell cycle inhibition and suppression of apoptosis[J].J Interferon Cytokine Res,
1999,19:1351-1361.
21. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression mechanisms and consequences[J]. Cancer Res, 2005, 65: 3980-3985.
22. Duman-Scheel M, Weng L, Xin S, et al. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E[J]. Nature, 2002,417:299-303
23. Regl G, Kasper M, Schnidar H ,et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal t ransduction is predominantly mediated by GLI2[J] . Cancer Res, 2004,64:7724-7731.
24. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis[J]. Proc Natl Acad Sci USA. 2007,104:5103-5108.
1.Vermes I,Haanen C,Steffens-Nakken H,et al.A novel assay for apoptosis:flow
cytometric detcetion of phosphatidylserine expression onearly apoptotic cells using
fluorescein labeled AnnexinV[J].J Immunol Methods,1995,184:39-51
2.Hugo van Genderen,Heidi Kenis,Petra Lux,et al.In vitro measurement of cell death
with the annexin A5 affinity assay[J].Nature protocol,2006,1:363-367.
3.Huang Z.The chemical biology of apoptosis.Exploring protein-protein interactions
and the life and death of cells with small molceules[J].Chem Biol.2002,9:1059-1072.
4.Jean-Baptiste Charrier,Frangoise Lapointe,Nicole M.Anti-apoptotic role of Sonic
hedgehog protein at the early stages of nervous system organogenesi[J].Development, 2001,128:4011-4020.
5.Varas A, Hernandez-Lopez C, Valencia J, et al. Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling[J]. J Leukoc Biol, 2008;83:1476-1483.
6.Venters SJ and Ordahl CP. Persistent myogenic capacity of the dermomyotome dorsomedial lip and restriction of myogenic competence[J]. Development, 2003;129:3873-3885.
7.Coffman CR, Strohm RC, Oakley FD, et al. Identification of X-linked genes required for migration and programmed Cell death of drosophila melanogaster germ Cells[J].Genetics, 2002; 162:273-284.
8.McCarthy RA, Barth JL, Chintalapudi MR, et al. Megalin functions as an endocytic sonic hedgehog receptor[J]. J Biol Chem, 2002; 277:25660-25667.
9.Yuzhu T, Elzbieta A. Swietlicki, et al. Increased apoptosis and accelerated epithelial migration following inhibition of hedgehog signaling in adaptive small bowel post-resection[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290:1280-1288.
10.Thayer SS,di Magliano MP, Patrick W Heiser, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425: 851-856.
11.Sheng G,Guo J, and Warner BW. Epidermal growth factor receptor signaling modulates apoptosis via p38α MAPK-dependent activation of Bax in intestinal epithelial cells[J]. Am J Physiol Gastrointest Liver Physiol, 2007; 293:599-606.
12.Narita S, So A, Ettinger S, et al. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer[J]. Clin Cancer Res. 2008 14:5769-5777.
13.Liao X, Siu MK, Au CW, et al. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis.2009,30:131-40.
14.Tanori M, Mancuso M, Pasquali E, et al. PARP-1 cooperates with Ptcl to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis. 2008 29:1911-1919.
15.Warzecha J, Bonke L, Koehl U, et al. The hedgehog inhibitor cyclopamine induces apoptosis in leukemic cells in vitro[J]. Leuk Lymphoma. 2008; 49:2383-2386.
16.Lindemann RK. Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res. 2008; 68:961-964.
17.Qualtrough D, Buda A, Gaffield W, et al. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment[J]. Int J Cancer, 2004; 110:831-837.
18.Li P, Nijhawan D, Budihardjo I, et al. Cytochrome C and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade[J]. Cell, 1997, 91:479-489.
19.Yang J , Liu X , Bhalla K, et al. Prevention of apoptosis by Bc1-2: release of cytochrome c from mitochondria blocked[J]. Science, 1997 ,275 :1129-1132.
20.Kato J, Kuwabara Y, Mitana M , et al.Expression of survivin in esophageal cancer:correlation with the prognosis and response to chemotherapy[J].Int J Cancer , 2001,95:92-95.
21.Manion MK and Hoekenbery DM. Targeting Bcl-2 related proteins in cancer therapy[J].Cancer Biol Ther, 2003, 2: 5105-5114.
22.Regl G,Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004;64:7724-7731.
23.Krajewska M, Wang HG,Krajewski S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease[J]. Cancer Res,1997, 57: 1605-1613.
24.Fujikawa K, Shiraki K, Sugimoto K, et al . Reduced expression of ICE/Caspase 1 and CPP32/ Caspase 3 in human hepatocellular carcinoma [J] Anticancer Res , 2000, 20:1927-1932.
25.Abe Y,Oda-Sato E,Tobiume K,et al.Hedgehog signaling overrides p53-mediated
tumor suppression by activating Mdm2[J].Proc Natl Acad Sci U S A.2008,
105:4838-4843.
26.Sabbatini P,Han J,Chiou SK,et al.Interleukin 1 beta converting enzyme-like
proteases are essential for p53-mediated transcriptionally dependent apoptosis[J].Cell
Growth Differ,1997,8:643-653.
27.Jin YH,Yoo KJ,Lee YH,et al.Caspase 3-mediated cleavage of p21 associated with
the cyclin A-cyclin-dependent kinase 2 comoplex is a prerequisite for apoptosis in
SK-HEP-1 cell[J].J Biol Chem,2000,275:30256-30263.
1． 陈孝平，裘法祖，吴在德．原发性肝癌要按个体化采用以手术为主的综合治疗[J]．中华外科杂志，2003，41：161-162．
2．晋云，董家鸿．肝癌转移机制研究进展[J]．西南国防医药，2008，18：134-137．
3.Tang ZY,Ye SL,Liu YK,et al.A decade's studies on metastasis of hepatocellular carcinoma.J Cancer Res Clin Oncol,2004,130:187
4.Changqing Yang,Michael Zeisberg,Julie C,et al.Integrin α1β1 and α2β1 are the key regulators of hepatocarcinoma cell Invasion across the fibrotic matrix microenvironment[J].Cancer Res,2003,63:8312-8317.
5.Takeichi M.Cadherin cell adhesion receptors as a morphogenetic regulator.Science.1991,251:1451-1455.
6.Becker KF,Kremmer E,Eulitz M,et al.Analysis of E-cadherin in diffuse-type gastric cancer using a mutation specific monoclonal antibody[J].Am J Pathol,1999,155:1803-1809.
7.Vogt A,PT Chuang,et al.Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein[J].Science,2004,199:753-761.
8.Yang Y,Rao R,Shen J,et al.Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion[J].Cancer Res,2008,68:4833-4842
9.Perl AK,Wligenbus P,Dahl U,et al.Expressionof p-cadherin identifies prostate specific-antigen-negative cells inepithelial tissues of male sexual accessory organs and in prostatic carcinomas[J].Nature,1998,392:1901-1903.
10.Osada T,SakamotoM,Ino Y,et al.E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma[J].Hepatology,1996,24:1460-1467.
11.Stambolic V,Mak TW,Woodgett JR.Modulation of cellular apoptotic potential:contributions to oncogenesis[J].Oncogene,1999;18:6094-6103.
12.Thiery JP.Epithelial-mesenchymal transitions in tumour progression[J].Nat Rev Cancer 2002;2:442-454
13.Mayer B,Johnson JP,Leitl F,et al.E-cadherin expression in primary and metastatic gastric cancer:Down-regulation correlates with cellular dedifferentiation and glandular disintegration[J].Cancer Res,1993,53:1690-1695.
14.Moll R,MitzeM,Frixen UH,et al.Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas[J].Am J Pathol,1993,143:1731-1742.
15.Krishnadath KK,Tilanus HW,van Blankenstein M,et al.Reduced expression of the eadherin-catenin comp lex in oesophageal adenocarcinoma correlates with poor p rognosis[J].J Pathol,1997,182:331-338
16．姚昱，周信达，刘银坤，等．上皮型钙粘蛋白(E-cad)在高侵袭性肝细胞癌中的表达[J]．中华消化杂志，1998，18：33-35．
17．成峰，王学浩，钱建民，等．E-钙粘蛋白、syndecan-1蛋白在HCC中的表达与肝癌侵袭的关系[J]．中华普通外科杂志，2003，3：141-142．
18.Wei Y,Van Nhieu JT,Prigent S,et al.Altered expression of E-cadherin in hepatocellular carcinoma:correlations with genetic alteratin,beta-catenin expression,and clinical feature[J].Hepatology,2002,36:692-701.
1.Nusslein-Vblhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287: 795-801.
2.Bertrand N and Dahmane N. Sonic hedgehog signaling inforebrain development and its interactions with pathways that modity its effeets[J]. Trends Cell Biol, 2006,116:597-605.
3.di Marcotullio L, Ferretti E, Greco A, et al. Multiple ubiquitin-dependent processing pathways regulate hedgehog/gli signaling: implications for cell development and tumorigenesis[J]. Cell Cycle, 2007, 6:390-393.
4.Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol, 2005,6: 306-317
5.Elia D, Madhala D, Ardon E, et al. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways[J]. Biochim Biophys Acta 1773: 1438-1446,2007.
6.Palma V, Lim DA, Dahmane N, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain[J]. Development, 2005, 132: 335-344.
7.Beachy PA, Karhadkar SS, Berman DM: Tissue repair and stem cell renewal in carcinogenesis[J]. Nature, 2004, 432:324-331.
8.Pathi S. Comparative biological responses to human Sonic, Indian and Desert hedgehog[J]. Mech Dev, 2001, 106:107-117.
9.Ruiz I Altaba A, Palma V, Dahmane N. Gli and hedgehog in cancer: tumor, embryos and stem cells[J]. Nat Rev Cancer, 2002, 2:361-372.
10.McMahon AP, Ingham PW, Tabin CJ. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol, 2003, 53:1-114.
11.Kayed H, Kleeff J, Keleg S, et al. Distribution of Indian hedgehog and its receptors patched and smoothened in human chronic pancreatitis[J]. J Endocrinol, 2003,178:467-478.
12.Carpenter D, Stone DM, Brush J, et al. Characterization of two patched receptors for the vertebrate hedgehog protein family[J]. Proc Natl Acad Sci USA, 1998, 95:13630-13634.
13.Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles[J]. Genes Dev, 2001,15:3059-3087.
14.Hooper JE. Smoothened translates Hedgehog levels into distinct responses[J].Development, 2003,130:3951-3963.
15.Chen Y, Struhl G. Dual roles for patched in sequestering and transducing Hedgehog[J].Cell, 1996, 87:553-563.
16.Ruiz I Altaba A. Gli protein and hedgehog signaling in development and cancer[J].Trends Genet, 1999,15:481-425.
17.Kalderon D. Hedgehog signaling: Costa1-2 bridges the transduction gap[J]. Curr Biol,2004,14:64-69.
18.Jiang J, Srtuhl G. Regulation of the Hedgehog and Wingless signaling pathway by the F-box/WD40-repeat protein Slinmb[J]. Nature, 1998, 391:493-496.
19.Kinzler KW, Bingner SH, Bigner DD, et al. Identification of an amplified, highly expressed gene in a human glioma [J]. Science, 1987,236:70-73.
20.Ruiz i Altaba A, Nguyen V, Palma V, et al. The emergent design of the neural tube:prepattern, SHH morphogen and GLI code[J]. Curr Opin Genet Dev, 2003, 13:513-521.
21.Ruiz I Altaba A. Catehing a Gli-mpse of Hedgehog[J]. 1997,190:193-196.
22.Nataka K, Nagai T, Aruga J, et al. Xenopus Zic family and its role in neural and neural crest development[J]. Mech Dev, 1998, 75:43-51.
23. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma[J]. Nat Genet, 2003, 31:306-310.
24. Mullor JL, Sanchez P, Altaba AR. Pathways and consequences: Hedgehog signaling in human disease[J]. Trends Cell Biol, 2002,12:562-569.
25. Chuang PT, McMahon AP. Vertebrate Hedgehog signaling modulated by induction of a Hedgehog-binding protein[J]. Nature, 1999,397:617-621.
26. Keeler, RF, Binns, W. Chemical compounds of Veratrum californicum related to congenital ovine cyclopian malformations. Extraction of active material. Proc.Soc.Exp. Biol. Med. 1964, 116,123-127.
27. Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine[J]. Nature, 2000,406: 1005-1009.
28. Chen JK, Taipale J, Cooper MK, et al. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened[J]. Genes & Develop. 2002,16, 2743-2748.
29. Chen JK, Taipale J, Young KE, et al. Small molecule modulation of Smoothened activity[J]. Proc Natl Acad Sci USA, 2002, 99: 14071-14076.
30. Yang TY, Chen SC, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus and induces an angioproliferative disease resembling Kaposi's sarcoma[J]. J Exp Med, 2000, 191:445-454.
31. Williams JA, Guieherit MO, et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell careinoma-like lesions[J]. Proc Natl Acad Sci USA, 2003, 100:4616-4621.
32. Curis Inc: Curis receives approval to start phase I clinical trial of CUR-61414 for treatment of sporadic basal cell carcinoma-new therapeutic approach offers patients an alternative to surgery. Press Release, 2001:5.
33. Curis Inc: Genentech and Curis halt development of topical Hedgehog antagonist for skin cancer. Press Release (2006):July 12.
34. Kinzler KW, Bingner SH, Bingner DD, et al. Identification of an amplified, highly expressed gene in a human glioma [J]. Science, 1987, 236:70-73.
35. Zurawel RH, Allen C, Wechaler-Reya, et al. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice[J]. Genes Chromosomes Cancer, 2000, 28: 77-81.
36. Smyth I, Narang MA, Evans T, et al. Isolation and characerization of human patched2(PTCH2), a putative tumor suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome lp32[J]. Hum Mol Genet, 1999, 8:291-297.
37. Reifenberger J, Wolter M, Weber RG, et al. Missense mutation in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroeetodermal tumors of the central nervous system[J]. Cancer Res, 1998,58:1798-1803.
38. Xie J, Murone M, Luoh SM, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma[J]. Nature, 1998,391:90-92.
39. Hahn H, Wicking C, Zaphiropoulos PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 1996, 85:841-851
40. Hahn H, Christiansen J, Wicking C,et al. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities[J]. J Biol Chem. 1996; 271:12125-12128.
41. Dahmane N , Sanchez P , Gitton Y, et al. The Sonic Hedgehog-Gli pat hway regulates dorsal brain growt h and tumorigenesis[J]. Dev, 2001,128:5201-5212.
42. Berman DM , Karhadkar SS , Hallahan AR , et al. Medulloblastoma growth inhibition by hedgehog pat hway blockade[J]. Science, 2002, 297:1559-1561.
43. Lee Y, Kawagoe R , Sasai K, et al . Loss of suppressor of fused function promotes tumorigenesis[J]. Oncogene,2007,26: 6442-6447.
44. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Human Mol.Genet. 2001,10:757-762
45. Dahmane N, Lee J, Robins P, et al. Activation of the transcription factor Glil and the Sonic hedgehog signalling pathway in skin tumours[J]. Nature, 1997, 389: 876-881.
46. Booth DR. The hedgehog signalling pathway and its role in basal cell carcinoma. Cancer Metastasis Rev, 1999,18: 261- 284.
47.Nilsson M, Unden AB, Krause D, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci U S A , 2000, 97:3438- 3843.
48.Vogt A, Chuang PT, et al. Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein[J]. J Exp Med, 2004,199:753-761.
49.Thayer S P, Di Magliano M P, Heiser P W,et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003,425: 851-856.
50.Berman DM, Karhadkar SS, Maitra A, et al. Wide spread requirement for Hedgehog ligand stimulation in growth of digestive tract tumour[J]. Nature, 2003,425:846-851
51.Georg F, Nils H, Surajit D, et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer[J]. Gut. 2008, 57:1420-1430.
52.Hu WG, Liu T, Xiong JX, Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells[J]. Acta Pharmacol Sin, 2007,28: 1224-1230.
53.Vanchieri C.Scientists hopeful as they uncover molecular clues to prostate cancer[J].JNCI,2005, 97:168-170.
54.Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 2004, 431:707-712.
55.Sanchez P, Hernandez AM, Stecca B, et al.Inhibition of prostate cancer proliferation by interference with sonic hedgehog-glil signaling. Proc Natl Acad Sci, 2004, 101:12561-12565
56.Saravanan T, Neehar B, Shannon RS, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells[J]. Cancer Res, 2007, 67: 10642-10646
57.Fan L, Pepicelli CV, Dibble CC, et al. Hedgehog signaling promotes prostate xenograft tumor growth[J]. Endocrinology, 2004, 145: 3961-3970.
58. Sanchez P, Hernandez AM, Stecca B, et al. Inhibition of p rostate cancer p roliferation by interference with Sonic hedgehog-Gli-lsignaling[J]. Proc Natl Acad Sci USA, 2004,101: 12561-12566.
59. Michael T Lewis.Hedgehog signaling in mouse mammary gland development and neoplasia[J].J Mammay Gland Biol Neopl, 2001,6(l):53-66.
60. Xie J, Johnson RL, Zhang X, et al. Mutations of PATCHED gene in several types of sporadic extracutaneous tumor[J]. Cancer Res, 1997, 57:2369-2372.
61. Kubo M, Nakamura M, Tasaki A et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer[J]. Cancer Res, 2004, 64: 6071-6074.
62. Sterling JA, Oyajobi BO, Grubbs B, et al. The Hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells[J]. Cancer Res 2006; 66: 7548-7554.
63. Monzo M, Relano E, Gutirrez J, et al. Sonic hedgehog(Shh) mutations in resected non-small cell lung cancer (NSCLC). Lung Cancer, 2000,29: 187-188.
64. Watkins DN , Berman DM, Baylin SB. Hedgehog signaling: progenitor phenotype in small2cell lung cancer[J]. Cell Cycle, 2003,2:196-198.
65. Mori Y, Okumura T, Tsunoda S, et al. Gli-1 Expression Is Associated with Lymph Node Metastasis and Tumor Progression in Esophageal Squamous Cell Carcinoma[J].Oncology, 2006, 70: 378-389.
66. Ma X, Chen K, Huang S, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas[J]. Carcinogenesis, 2005, 26: 1698-1705.
67. Olsen CL, Hsu PP, Glienke J, et al. Hedgehog-interacting protein is highly expressed in endothelial cells, but down-regulated during angiogenesis and in several human tumors[J]. BMC Cancer, 2004, 4: 43.
68. Volker F, Waldmann J, Farzad E, et al. Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum[J]. Endocrine Related Cancer, 2007,14: 865-874.